妇科肿瘤医生微创手术当日出院:患者选择综述
本系统综述纳入9项研究共16423例患者,评估妇科肿瘤医生实施的微创手术后当日出院(SDD)的安全性与可行性。SDD组与住院组术后30天内并发症及再入院率无统计学显著差异。作者提出的选择标准包括年龄小于70岁、下午1点前手术、手术时间小于2小时且无术中并发症。
要点
- SDD在妇科肿瘤微创手术中似乎安全可行,术后30天并发症与再入院率无显著增加。
- 与住院相关的常见因素:年龄小于70岁、下午1点后手术、手术时间超过2小时、术中并发症。
- 作者提出的选择标准:年龄小于70岁、下午1点前手术、手术时间小于2小时、无术中并发症。
核心结论
- SDD在妇科肿瘤医生实施的微创手术中似乎安全可行。
- 作者提出的选择标准包括:年龄小于70岁、下午1点前手术、手术时间小于2小时且无术中并发症。
研究设计与样本
- 系统综述,检索PubMed、EMBASE、Cochrane中央对照试验注册库和SCOPUS从2007年5月至2019年5月的文献。
- 纳入9项研究,共16423例因生殖道良恶性疾病接受妇科肿瘤医生实施的微创手术(机器人或腹腔镜)并接受SDD或住院的女性。
主要发现
- 各研究并发症发生率不一,仅2项研究显示SDD组在术中并发症和伤口并发症方面具有优势。
- 采用SDD后术后30天内并发症无统计学显著差异。
- SDD组与住院组术后30天内再入院率无统计学显著差异。
- 与住院相关的常见因素包括:年龄小于70岁、下午1点后手术、手术时间超过2小时、术中并发症。
- 其他需考虑的因素包括:存在需要术后院内随访的合并症、充分的术后评估以及患者接受SDD。
关键数值与推荐
- 作者提出的选择标准:年龄小于70岁、下午1点前手术、手术时间小于2小时、无术中并发症。
临床怎么用
- 作者认为SDD在妇科肿瘤医生实施的微创手术中似乎安全可行,并提出了上述选择标准。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To review the literature about same-day discharge (SDD) in minimally invasive surgery performed by gynecologic oncologists and identify factors associated with SDD and admission to provide selection criteria. DATA SOURCES: Systematic review of PubMed, EMBASE, Cochrane Central Register of Controlled Trials, and SCOPUS between May 2007 and May 2019. The search included the following medical subject heading terms and keywords: "same day discharge," "patient discharge," "minimally invasive surgical procedures," "hysterectomy," "gynecologic malignancy," "gynecologic neoplasm," "cervical cancer," "ovarian cancer," and "endometrial cancer." METHODS OF STUDY SELECTION: Articles published in English about women who underwent minimally invasive procedures for benign and malignant conditions of the reproductive tract performed by gynecologic oncologists (robotic or laparoscopic) and who received SDD or admission were included. The following were described: SDD and admission rate, readmission or unscheduled evaluation rates within 30 days after surgery, and associated factors for each one. TABULATION, INTEGRATION, AND RESULTS: Nine studies with a total of 16 423 patients were included. The complication rates in the studies were variable, with only 2 studies showing advantages in the SDD group with respect to intraoperative complications and wound complications. There were no statistically significant differences in postoperative complications in the first 30 days after the adoption of SDD. There were no higher readmission rates within the first 30 days in the group of patients who were discharged on the same day vs those admitted. The common factors associated with admission were as follows: age <70 years, surgery after 1 PM, duration of surgery more than 2 hours, and intraoperative complications. Other factors to consider were the presence of comorbidities that require follow-up within the hospital after surgery, adequate postoperative evaluation, and the patient accepting SDD. CONCLUSION: SDD seems to be safe and feasible in minimally invasive surgery performed by gynecologic oncologists. The proposed selection criteria includes the following: younger than 70 years, surgery before 1 PM, procedure less than 2 hours, and no intraoperative complications.
引用
- Sanabria D, Rodriguez J, Pecci P, et al. Same-Day Discharge in Minimally Invasive Surgery Performed by Gynecologic Oncologists: A Review of Patient Selection. J Minim Invasive Gynecol. 2019. PMID: 31715304. doi:10.1016/j.jmig.2019.10.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。